ABOS vs. AVR

Last updated Apr 1, 2026

Compare and contrast key facts about Acumen Pharmaceuticals, Inc. (ABOS) and Anteris Technologies Global Corp (AVR).

Performance

ABOS vs. AVR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Acumen Pharmaceuticals, Inc. (ABOS) and Anteris Technologies Global Corp (AVR). The values are adjusted to include any dividend payments, if applicable.

ABOS vs. AVR - Yearly Performance Comparison

	2026 (YTD)	2025	2024
ABOS Acumen Pharmaceuticals, Inc.	11.85%	22.67%	-15.27%
AVR Anteris Technologies Global Corp	11.22%	-10.57%	-0.36%

Fundamentals

EPS ABOS : -$2.00 AVR : -$5.98
Total Revenue (TTM) ABOS : -$90.00K AVR : $1.91M
Gross Profit (TTM) ABOS : -$45.00K AVR : $1.34M
EBITDA (TTM) ABOS : -$118.08M AVR : -$63.54M

Returns By Period

In the year-to-date period, ABOS achieves a 11.85% return, which is significantly higher than AVR's 11.22% return.

ABOS

• 1D: 7.76%
• 1M: -24.84%
• YTD: 11.85%
• 6M: 38.01%
• 1Y: 114.55%
• 3Y*: -16.54%
• 5Y*: —
• 10Y*: —

AVR

• 1D: 8.61%
• 1M: -14.75%
• YTD: 11.22%
• 6M: 23.33%
• 1Y: 52.47%
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

ABOS vs. AVR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ABOS

ABOS Risk / Return Rank: 81
ABOS Sharpe Ratio Rank: 80
ABOS Sortino Ratio Rank: 82
ABOS Omega Ratio Rank: 74
ABOS Calmar Ratio Rank: 84
ABOS Martin Ratio Rank: 83

AVR

AVR Risk / Return Rank: 62
AVR Sharpe Ratio Rank: 59
AVR Sortino Ratio Rank: 69
AVR Omega Ratio Rank: 61
AVR Calmar Ratio Rank: 62
AVR Martin Ratio Rank: 58

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ABOS vs. AVR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Acumen Pharmaceuticals, Inc. (ABOS) and Anteris Technologies Global Corp (AVR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	ABOS	AVR	Difference
Sharpe ratio Return per unit of total volatility	1.27	0.52	+0.76
Sortino ratio Return per unit of downside risk	2.21	1.60	+0.61
Omega ratio Gain probability vs. loss probability	1.24	1.17	+0.08
Calmar ratio Return relative to maximum drawdown	2.81	0.97	+1.84
Martin ratio Return relative to average drawdown	6.96	1.83	+5.13
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

ABOS vs. AVR - Sharpe Ratio Comparison

The current ABOS Sharpe Ratio is 1.27, which is higher than the AVR Sharpe Ratio of 0.52. The chart below compares the historical Sharpe Ratios of ABOS and AVR, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	ABOS	AVR	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.27	0.52	+0.76
Sharpe Ratio (All Time) Calculated using the full available price history	-0.37	-0.01	-0.36

Correlation

The correlation between ABOS and AVR is 0.20, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

ABOS vs. AVR - Dividend Comparison

Neither ABOS nor AVR has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

ABOS vs. AVR - Drawdown Comparison

The maximum ABOS drawdown since its inception was -95.56%, which is greater than AVR's maximum drawdown of -71.46%. Use the drawdown chart below to compare losses from any high point for ABOS and AVR.

Drawdown Indicators

	ABOS	AVR	Difference
Max Drawdown Largest peak-to-trough decline	-95.56%	-71.46%	-24.10%
Max Drawdown (1Y) Largest decline over 1 year	-35.01%	-47.37%	+12.36%
Current Drawdown Current decline from peak	-88.36%	-35.88%	-52.48%
Average Drawdown Average peak-to-trough decline	-76.87%	-39.17%	-37.70%
Ulcer Index Depth and duration of drawdowns from previous peaks	14.13%	25.20%	-11.07%

Volatility

ABOS vs. AVR - Volatility Comparison

Acumen Pharmaceuticals, Inc. (ABOS) has a higher volatility of 21.75% compared to Anteris Technologies Global Corp (AVR) at 17.57%. This indicates that ABOS's price experiences larger fluctuations and is considered to be riskier than AVR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ABOS	AVR	Difference
Volatility (1M) Calculated over the trailing 1-month period	21.75%	17.57%	+4.18%
Volatility (6M) Calculated over the trailing 6-month period	65.71%	55.11%	+10.60%
Volatility (1Y) Calculated over the trailing 1-year period	90.80%	101.97%	-11.17%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	98.32%	96.57%	+1.75%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	98.32%	96.57%	+1.75%

Financials